About URRMA R&D
The URRMA R&D laboratory near Marseille, France is dedicated to development of innovative therapies for the treatment of HIV-infected patients and diagnostic tools for HIV.
Led by distinguished researcher Professor Jean-Claude Chermann, URRMA has successfully developed and produced anti-R7V antibodies capable of neutralizing all HIV isolates in patients escaping from highly active anti-retroviral therapy (HAART).
URRMA offers a unique and exciting partnering opportunity requiring investment funding specifically directed towards an ongoing development to commercialisation programme for anti-HIV biological products for both therapeutic use as well as for prophylactic use in HIV-infected subjects.
The laboratory is also specialised in HIV diagnostics and it offers its services as a contract research organisation (CRO) for developing novel biopharmaceuticals and the supporting diagnostic tools for the benefit of URRMA's partners and its customers who are active in the field of HIV and related diseases.
